Other companies, domestic and foreign, have recently warned customers that price hikes related to tariffs are on the way.

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish ...

The test can aid doctors in determining whether a patient's memory problems are due to Alzheimer's or a number of other ...

The order aims to slash drug prices by up to 80%. Indian industry had been on edge since March amid threats of reciprocal tariff on pharmaceutical products.

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Pedersen and Stine Jacobsen COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday ...

When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge ...

Can prescription benefit managers, or PBMs, be eliminated from the U.S. drug pricing process? Seeking Alpha analysts weigh in. Read more here.

The S&P 500 rose for a fourth straight day on Thursday, riding a relief rally in response to the U.S. and China agreeing to ...

President Donald Trump imposed a minimum tariff of 10% on almost all countries, before later suspending the measures ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...